The Helping People Heal white paper provides a deeply researched perspective on how digital is uniquely positioned to fulfill key unmet patient needs and enable warm care with individualized, adaptive, empathetic and scalable support.
The U.S., Japan and Eurozone remain the key markets for most companies, but the increasing focus on cost effectiveness and the difficulties of the general economy, make the potential for significant growth in these markets questionable. In contrast, emerging pharmaceutical markets have been growing in the double-digits and are expected to continue expanding in the years ahead, due to strong economic growth, demographic changes, and improved funding for health care.
Most of our work in health care involves new research and our approach to it always involves more than just one stakeholder, taking several stakeholders in the specific disease ecology into account. In our experience, it is through understanding different stakeholders’ perspectives that new insights can be found and new solutions developed thereafter.